Polycystic Ovarian Syndrome (PCOS) Treatment Market - Expected to Reach $5 Billion by 2025 - Research and Markets

DUBLIN--()--The "Polycystic Ovarian Syndrome (PCOS) Treatment Market, 2014-2025" report has been added to Research and Markets' offering.

The global polycystic ovarian syndrome treatment market is expected to reach USD 5.1 billion by 2025, according to a new report. According to the Centers of Disease Control & Prevention (CDC), Polycystic Ovary Syndrome (PCOS) is the most common cause of female infertility. Approximately 6% to 12% women of reproductive age suffer from PCOS in the U. S. Moreover, progression of this condition can lead to metabolic abnormalities, which may result in development of type 2 diabetes, if the syndrome is not treated on time. The severity of the disorder increases the risk of developing uterine and endometrial cancers in patients. Thus, early diagnosis and effective treatment are significant for successful recovery.

Presently, no specific drug is commercially available for this condition. Thus, treating symptoms is the prime aim of the treatment regimen. Owing to the various symptoms associated with this syndrome, a range of drug class/combinations is used in the treatment. Therefore, market leaders are focusing on developing a specific drug/treatment to cure the root cause of this disease. AstraZeneca is one of the leaders involved in developing such a drug.

Companies Mentioned

  • AstraZeneca
  • Bayer AG
  • Merck KGaA
  • Abbott Laboratories
  • Pfizer Inc.
  • Sanofi SA
  • Bristol-Myers Squibb Company
  • Ferring Pharmaceuticals, Inc.
  • Teva Pharmaceuticals Industries Limited
  • Novartis AG

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Polycystic Ovarian Syndrome (PCOS) Treatment Market Variables, Trends & Scope

Chapter 4 Polycystic Ovarian Syndrome (PCOS) Treatment Market: Drugs Estimates & Trend Analysis

Chapter 5 Polycystic Ovarian Syndrome (PCOS) Treatment Market: Surgery Estimates & Trend Analysis

Chapter 6 Polycystic Ovarian Syndrome (PCOS) Treatment Market: Regional Estimates & Trend Analysis, by Drugs and Surgery

Chapter 7 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/mc8wrs/polycystic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Women's Health, Surgical Procedures , Sexual and Reproductive Health Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Women's Health, Surgical Procedures , Sexual and Reproductive Health Drugs